Is ULIX or MRK a better dividend investment in 2026?

ULIX currently yields 5000.00% with a 5% 5-year dividend growth rate. MRK yields 2.76% with 8.2% growth. The better choice depends on your goal: ULIX offers higher current income.

What is the dividend yield difference between ULIX and MRK?

ULIX has a forward dividend yield of 5000.00% ($2.00/share annually). MRK yields 2.76% ($3.32/share annually). The yield gap is 4997.24 percentage points.

Home › Compare › ULIX vs MRK

ULIX vs MRK: Dividend Comparison 2026

ULIX yields 5000.00% · MRK yields 2.76%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 ULIX wins by $62217131802825.30M in total portfolio value

INVESTMENT

TIME HORIZON10 years

ULIX

● Live price

5000.00%

Share price

$0.04

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$62217131802825.35M

Annual income

$59,861,980,287,378,210,000.00

Full ULIX calculator →

MRK

Merck & Co. Inc.

● Live price

2.76%

Share price

$120.31

Annual div

$3.32

5Y div CAGR

32.7%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$56.8K

Annual income

$9,798.13

Full MRK calculator →

Portfolio growth — ULIX vs MRK

📍 ULIX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	ULIX	MRK
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, ULIX + MRK cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

ULIX pays

MRK pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ULIX

Annual income on $10K today (after 15% tax)

$425,000.00/yr

After 10yr DRIP, annual income (after tax)

$50,882,683,244,271,480,000.00/yr

MRK

Annual income on $10K today (after 15% tax)

$234.56/yr

After 10yr DRIP, annual income (after tax)

$8,328.41/yr

At 15% tax rate, ULIX beats the other by $50,882,683,244,271,470,000.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ULIX + MRK for your $10,000?

ULIX: 50%MRK: 50%

100% MRK50/50100% ULIX

Portfolio after 10yr

$31108565901412.70M

Annual income

$29,930,990,143,689,110,000.00/yr

Blended yield

96.21%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

ULIX

No analyst data

Altman Z

22.0

Piotroski

2/9

MRK

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$128.54

+6.8% upside vs current

Range: $100.00 — $150.00

Altman Z

4.0

Piotroski

6/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ULIX buys

MRK buys

No recent congressional trades found for ULIX or MRK in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricULIXMRK

Forward yield	5000.00% ✓	2.76%
Annual dividend / share	$2.00	$3.32 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	32.7% ✓
Portfolio after 10y	$62217131802825.35M ✓	$56.8K
Annual income after 10y	$59,861,980,287,378,210,000.00 ✓	$9,798.13
Total dividends collected	$62057786341622.61M ✓	$28.9K
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: ULIX vs MRK ($10,000, DRIP)

Year	ULIX Portfolio	ULIX Income/yr	MRK Portfolio	MRK Income/yr	Gap
1← crossover	$510,700	$500,000.00	$11,206	$366.19	+$499.5K → ULIX
2	$24,410,935	$23,864,485.98	$12,650	$502.35	+$24.40M → ULIX
3	$1,092,192,501	$1,066,072,800.30	$14,407	$694.19	+$1092.18M → ULIX
4	$45,746,366,951	$44,577,720,975.17	$16,585	$967.82	+$45746.35M → ULIX
5	$1,793,932,828,410	$1,744,984,215,772.56	$19,342	$1,363.89	+$1793932.81M → ULIX
6	$65,871,973,805,320	$63,952,465,678,921.49	$22,913	$1,947.19	+$65871973.78M → ULIX
7	$2,265,146,887,602,700	$2,194,663,875,631,007.20	$27,662	$2,823.89	+$2265146887.58M → ULIX
8	$72,954,689,148,998,180	$70,530,981,979,263,280.00	$34,159	$4,173.35	+$72954689148.96M → ULIX
9	$2,201,076,182,660,884,700	$2,123,014,665,271,456,500.00	$43,337	$6,308.80	+$2201076182660.84M → ULIX
10	$62,217,131,802,825,350,000	$59,861,980,287,378,210,000.00	$56,776	$9,798.13	+$62217131802825.30M → ULIX

ULIX vs MRK: Complete Analysis 2026

ULIX — Stock

Ulixe Corp., a development stage company, engages in the development of ride-hailing and food delivery computer and mobile device application in the United States. The company was formerly know as WarpSpeed Taxi Inc. and change its name to Ulixe Corp. in August 2025. The company was incorporated in 2020 and is based in Nairobi, Kenya. As of June 13, 2025, Ulixe Corp. operates as a subsidiary of Ulixe One Corp.

Full ULIX Calculator →

MRK — Healthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →

📬

Get this ULIX vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ULIX vs SCHD ULIX vs JEPI ULIX vs O ULIX vs KO ULIX vs MAIN ULIX vs JNJ ULIX vs ABBV ULIX vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.